SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) February 18, 2004
|
Specialty Laboratories, Inc. |
||||
|
(Exact name of registrant as specified in charter) |
||||
|
|
|
|
|
|
|
California |
|
001-16217 |
|
95-2961036 |
|
(State or other
jurisdiction |
|
(Commission |
|
(IRS Employer |
|
|
|
|
|
|
|
2211 Michigan Avenue, Santa Monica, California |
|
90404 |
||
|
(Address of principal executive offices) |
|
(Zip Code) |
||
|
|
|
|
|
|
|
Registrant’s telephone number, including area code (310) 828-6543 |
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
(Former name or former address, if changed since last report.) |
||||
|
ITEM 7 |
|
|
FINANCIAL STATEMENTS AND EXHIBITS |
|
|
|
|
|
|
|
|
|
(c) |
Exhibits |
The following document is filed as an exhibit to this report: |
|
|
|
|
|
|
|
|
|
|
99.1 |
Press Release dated February 18, 2004. |
|
ITEM 9 REGULATION FD DISCLOSURE
ITEM 12 RESULTS OF OPERATIONS AND FINANCIAL CONDITION
On February 18, 2004, Specialty Laboratories, Inc., (the “Registrant”) announced financial results for the fourth quarter and total year ended December 31, 2003. A copy of the press release issued by the Registrant on February 18, 2004 concerning the foregoing matter is filed herewith as Exhibit 99.1 and is incorporated herein by reference.
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
|
Specialty Laboratories, Inc. |
||||
|
|
|
||||
|
|
|
||||
|
Date: February 18, 2004 |
By: |
/s/ Frank J. Spina |
|
||
|
|
|
Frank J. Spina, |
|
||
|
|
|
Chief Financial Officer |
|
||
3
EXHIBIT INDEX
|
Exhibits |
The following document is filed as an exhibit to this report: |
|
|
|
|
99.1 |
Press Release dated February 18, 2004. |
4